awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35252908-4D74AE64-7AA6-4E9C-BBD6-E3228B0F3B4B
Q35252908-4D74AE64-7AA6-4E9C-BBD6-E3228B0F3B4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35252908-4D74AE64-7AA6-4E9C-BBD6-E3228B0F3B4B
Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study.
P2860
Q35252908-4D74AE64-7AA6-4E9C-BBD6-E3228B0F3B4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35252908-4D74AE64-7AA6-4E9C-BBD6-E3228B0F3B4B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cf8ec5abd9f08d0994d38ba16a555d566dd8cfd3
P2860
A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases.